NEW YORK, May 29, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced it will ...
The posters will be available on the Company website shortly after the presentations at https://ir.actiniumpharma.com/presentations-webinars. NYSE American Continued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results